The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118488674 11848867 4 F 201603 20160919 20151218 20160927 EXP US-ASTRAZENECA-2015SF24313 ASTRAZENECA 787.00 MON M Y 133.80000 KG 20160927 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118488674 11848867 1 PS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral U 21153 40 MG CAPSULE QD
118488674 11848867 2 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral GENERIC U 21153
118488674 11848867 3 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral U 21153 20 MG CAPSULE QD
118488674 11848867 4 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 0 40 MG CAPSULE QD
118488674 11848867 5 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 0 40 MG CAPSULE QD
118488674 11848867 6 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral GENERIC, 40 MG DAILY 0
118488674 11848867 7 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral GENERIC, 40 MG DAILY 0
118488674 11848867 8 SS PRILOSEC OTC OMEPRAZOLE MAGNESIUM 1 Oral U U 0 MODIFIED-RELEASE TABLET
118488674 11848867 9 C VERELAN PM VERAPAMIL HYDROCHLORIDE 1 Oral 0 400 MG QD
118488674 11848867 10 C VERELAN PM VERAPAMIL HYDROCHLORIDE 1 Oral 0 200 MG BID
118488674 11848867 11 C VASEPA 2 0 2 G BID
118488674 11848867 12 C BENICAR OLMESARTAN MEDOXOMIL 1 Oral 0 40 MG QD
118488674 11848867 13 C LESCOL XL FLUVASTATIN SODIUM 1 0 40 MG QD
118488674 11848867 14 C LESCOL XL FLUVASTATIN SODIUM 1 0 40 MG QD
118488674 11848867 15 C LESCOL XL FLUVASTATIN SODIUM 1 0 80 MG QD
118488674 11848867 16 C LESCOL XL FLUVASTATIN SODIUM 1 0 80 MG QD
118488674 11848867 17 C CHLORTHALID 2 0 12.5 MG BIW
118488674 11848867 18 C VITAMIN D3 CHOLECALCIFEROL 1 0 2000 IU QD
118488674 11848867 19 C PROAIR HFA ALBUTEROL SULFATE 1 ONCE IN AWHILE FOR 10 YEARS, AS REQUIRED 0
118488674 11848867 20 C PROAIR HFA ALBUTEROL SULFATE 1 ONCE IN AWHILE FOR 10 YEARS, AS REQUIRED 0
118488674 11848867 21 C PROAIR HFA ALBUTEROL SULFATE 1 ONCE IN AWHILE FOR 10 YEARS, AS REQUIRED 0
118488674 11848867 22 C OXYGEN. OXYGEN 1 ONCE A WEEK OR TWICE A WEEK MORE IN THE SUMMER 0
118488674 11848867 23 C HTCZ 2 0 12.5 MG BIW
118488674 11848867 24 C DIOVAN VALSARTAN 1 0
118488674 11848867 25 C VESCAPA 2 Oral 0 2 MG BID
118488674 11848867 26 C DEXILANT DEXLANSOPRAZOLE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118488674 11848867 1 Gastrooesophageal reflux disease
118488674 11848867 2 Gastrooesophageal reflux disease
118488674 11848867 3 Gastrooesophageal reflux disease
118488674 11848867 4 Gastrooesophageal reflux disease
118488674 11848867 5 Gastrooesophageal reflux disease
118488674 11848867 6 Gastrooesophageal reflux disease
118488674 11848867 7 Gastrooesophageal reflux disease
118488674 11848867 8 Gastrooesophageal reflux disease
118488674 11848867 9 Hypertension
118488674 11848867 10 Hypertension
118488674 11848867 11 Blood triglycerides abnormal
118488674 11848867 12 Hypertension
118488674 11848867 13 Blood triglycerides abnormal
118488674 11848867 14 Blood cholesterol abnormal
118488674 11848867 15 Blood triglycerides abnormal
118488674 11848867 16 Blood cholesterol abnormal
118488674 11848867 17 Diuretic therapy
118488674 11848867 18 Supplementation therapy
118488674 11848867 19 Dyspnoea
118488674 11848867 20 Asthma
118488674 11848867 21 Wheezing
118488674 11848867 22 Sleep disorder due to a general medical condition
118488674 11848867 25 Anticoagulant therapy

Outcome of event

Event ID CASEID OUTC COD
118488674 11848867 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118488674 11848867 Chest pain
118488674 11848867 Dehydration
118488674 11848867 Diarrhoea
118488674 11848867 Diplopia
118488674 11848867 Drug dispensing error
118488674 11848867 Drug dose omission
118488674 11848867 Drug hypersensitivity
118488674 11848867 Drug ineffective
118488674 11848867 Dyspnoea
118488674 11848867 Dyspnoea paroxysmal nocturnal
118488674 11848867 Limb discomfort
118488674 11848867 Loss of consciousness
118488674 11848867 Malaise
118488674 11848867 Migraine
118488674 11848867 Skin discolouration
118488674 11848867 Weight decreased
118488674 11848867 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118488674 11848867 4 1990 201607 0
118488674 11848867 5 1990 201607 0
118488674 11848867 6 201607 0
118488674 11848867 7 201607 0
118488674 11848867 10 1976 0
118488674 11848867 12 1976 0
118488674 11848867 13 1995 0
118488674 11848867 14 1995 0
118488674 11848867 15 2006 0
118488674 11848867 16 2006 0
118488674 11848867 22 2014 0